Stereoselective blockade of central [3H]5-hydroxytryptamine binding to multiple sites (5-HT1A, 5-HT1B and 5-HT1C) by mianserin and propranolol

J Pharm Pharmacol. 1987 Aug;39(8):664-6. doi: 10.1111/j.2042-7158.1987.tb03452.x.

Abstract

The interaction of the enantiomers of mianserin and propranolol with the binding of [3H]5-hydroxytryptamine ([3H]5-HT) to the 5-HT1A, 5-HT1B and 5-HT1C sites, and with the binding of [3H]ketanserin to the 5-HT2 site, has been evaluated in rat brain membranes. A stereoselective interaction at the 5-HT1A, 5-HT1B and 5-HT1C sites was demonstrated for both compounds, with (+)-mianserin being a more potent displacer than (-)-mianserin and (-)-propranolol being more potent than (+)-propranolol. Only mianserin interacted in a stereoselective manner with the 5-HT2 site, (+)-mianserin being the more potent isomer. The stereoselective association of mianserin and propranolol with the 5-HT1A, 5-HT1B and 5-HT1C sites may prove useful in the characterization of these sites.

MeSH terms

  • Animals
  • Brain Chemistry / drug effects
  • Corpus Striatum / drug effects
  • Corpus Striatum / metabolism
  • In Vitro Techniques
  • Ketanserin / metabolism
  • Male
  • Membranes / metabolism
  • Mianserin / pharmacology*
  • Propranolol / pharmacology*
  • Rats
  • Rats, Inbred Strains
  • Receptors, Serotonin / drug effects
  • Receptors, Serotonin / metabolism*
  • Serotonin / metabolism*
  • Stereoisomerism

Substances

  • Receptors, Serotonin
  • Mianserin
  • Serotonin
  • Ketanserin
  • Propranolol